Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
Abstract A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 P...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7c8c8c544c2b4347a40c5da25a5f23b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7c8c8c544c2b4347a40c5da25a5f23b4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7c8c8c544c2b4347a40c5da25a5f23b42021-12-02T18:18:52ZParkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration10.1038/s41531-021-00198-32373-8057https://doaj.org/article/7c8c8c544c2b4347a40c5da25a5f23b42021-07-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00198-3https://doaj.org/toc/2373-8057Abstract A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients’ networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases.G. CarolaD. MalagarrigaC. CalatayudM. Pons-EspinalL. Blasco-AgellY. Richaud-PatinI. Fernandez-CarasaV. BaruffiS. BeltramoneE. MolinaP. Dell’EraJ. J. Toledo-AralE. TolosaA. R. MuotriJ. Garcia OjalvoJ. SorianoA. RayaA. ConsiglioNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurology. Diseases of the nervous system RC346-429 G. Carola D. Malagarriga C. Calatayud M. Pons-Espinal L. Blasco-Agell Y. Richaud-Patin I. Fernandez-Carasa V. Baruffi S. Beltramone E. Molina P. Dell’Era J. J. Toledo-Aral E. Tolosa A. R. Muotri J. Garcia Ojalvo J. Soriano A. Raya A. Consiglio Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration |
description |
Abstract A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients’ networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases. |
format |
article |
author |
G. Carola D. Malagarriga C. Calatayud M. Pons-Espinal L. Blasco-Agell Y. Richaud-Patin I. Fernandez-Carasa V. Baruffi S. Beltramone E. Molina P. Dell’Era J. J. Toledo-Aral E. Tolosa A. R. Muotri J. Garcia Ojalvo J. Soriano A. Raya A. Consiglio |
author_facet |
G. Carola D. Malagarriga C. Calatayud M. Pons-Espinal L. Blasco-Agell Y. Richaud-Patin I. Fernandez-Carasa V. Baruffi S. Beltramone E. Molina P. Dell’Era J. J. Toledo-Aral E. Tolosa A. R. Muotri J. Garcia Ojalvo J. Soriano A. Raya A. Consiglio |
author_sort |
G. Carola |
title |
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration |
title_short |
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration |
title_full |
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration |
title_fullStr |
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration |
title_full_unstemmed |
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration |
title_sort |
parkinson’s disease patient-specific neuronal networks carrying the lrrk2 g2019s mutation unveil early functional alterations that predate neurodegeneration |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/7c8c8c544c2b4347a40c5da25a5f23b4 |
work_keys_str_mv |
AT gcarola parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT dmalagarriga parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT ccalatayud parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT mponsespinal parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT lblascoagell parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT yrichaudpatin parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT ifernandezcarasa parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT vbaruffi parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT sbeltramone parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT emolina parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT pdellera parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT jjtoledoaral parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT etolosa parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT armuotri parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT jgarciaojalvo parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT jsoriano parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT araya parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration AT aconsiglio parkinsonsdiseasepatientspecificneuronalnetworkscarryingthelrrk2g2019smutationunveilearlyfunctionalalterationsthatpredateneurodegeneration |
_version_ |
1718378164497940480 |